To analyze the efficacy and safety of cefoperazone sulbactam sodium combined with high-dose tigecycline in the treatment of interleukin (IL)-6, procalcitonin (PCT) and other indicators in patients with complicated urinary tract infection.
A total of 156 patients with complicated urinary tract infection caused by carbapenem-resistant Acinetobacter baumannii (CRAB) admitted to the Affiliated Hospital of Tangshan Vocational and Technical College from August 2020 to December 2023 were selected as retrospective study objects. The patients were divided into the high dose group and the routine dose group according to the dose of tigecycline, with 78 cases in each group. The initial dose of tigecycline in the high dose group was 200 mg, and the maintenance dose was 100 mg, twice a day. The initial dose of tigecycline in the routine dose group was 100 mg, and the maintenance dose was 50 mg, twice a day. The clinical efficacy, clinical indexes negative time, the laboratory indexe [IL-6, IL-8, hypersensitive C-reactive protein (hs-CRP) and PCT], the negative rate of urine culture, the incidence of adverse reactions and the oxidative stress indexes [noradrenaline (NE), glutathione peroxidase (GSH-PX), angiotensinogenⅡ (AngⅡ)] and treatment satisfaction were analyzed between the two groups.
The total clinical effective rate of the high-dose group was significantly higher than that of the routine dose group (P<0.05). The time of clinical symptoms disappearing, the time of urine white blood cell turning negative, and the time of fever reduction in the high-dose group were significantly shorter than those in the routine dose group (P<0.05). The levels of IL-6, IL-8, hs CRP, and PCT in the high-dose group were significantly lower than those in the routine dose group after treatment (P<0.05). The negative conversion rate of urine culture in the high-dose group was higher than that in the routine dose group (23.36% vs 12.82%, χ2=3.431, P=0.009). The total incidence of adverse reactions in the high-dose group was higher than that in the routine dose group (P>0.05), and the overall treatment satisfaction rate in the high-dose group was higher than that in the routine dose group (96.15% vs 82.05%, P<0.05). The levels of NE, GSH-Px, and AngⅡ in the high-dose group were significantly higher than those in the routine dose group after treatment (P<0.05).
High-dose tigecycline combined with cefoperazone-sulbactam sodium has significant efficacy in the treatment of CRAB induced complicated urinary tract infection, and the adverse reactions are not significantly higher than that of the routine dose regimen, and is safe and effective.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |